MedTrace Logo

Polish Microbiome Map

NCT04169867 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1160

Last updated 2019-11-20

No results posted yet for this study

Summary

Knowledge about the correlations between the composition of the gut microbiome and a wide range of diseases has substantially increased in recent years. Nonetheless, there is no reference set of information about the microbiome in Poland. The development of such a reference will allow polish scientists conducting research in the field of interaction between gut flora components and such characteristics as lifestyle, certain diseases or patient's responses for treatment. Following the example of such countries as the United States, investigators propose to build a unique set of scientific processed information describing the variability of the polish population microbiome (Polish Microbiome Map). The investigators will provide a reliable dataset that will characterize the gut microbiomes and their diversity in the polish population. Additionally, thanks to the creation of the standard protocol for microbiome data collection the research conducted by the MMP users will be comparable with the information deposited in MMP.

Conditions

  • Melanoma
  • Healthy Volunteers
  • Microbiome
  • Metagenome
  • Immunotherapy

Interventions

BIOLOGICAL

Collection of stool samples

Patients receiving routine treatment (immunotherapy using anti-PD1 / anti-PDL1 and / or anti CTLA4 antibodies), financed by the Polish National Health Fund (NFZ).

Sponsors & Collaborators

  • The Institute of Bioorganic Chemistry, Polish Academy of Sciences

    collaborator UNKNOWN

  • National Center for Research and Development, Poland

    collaborator OTHER

  • Ardigen

    lead INDUSTRY

Principal Investigators

  • Anna Philips, PhD · The Institute of Bioorganic Chemistry, Polish Academy of Sciences

  • Jan Majta · Ardigen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-07-31
Completion
2020-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04169867 on ClinicalTrials.gov